✦ LIBER ✦

EPA-0672 – Efficacy outcomes in age and sex subgroups from two clinical trials of lisdexamfetamine dimesylate in the treatment of adults with attention-deficit/hyperactivity disorder

✍ Scribed by Adler, L.A.; Dirks, B.; Adeyi, B.; Squires, L.A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical response and symptomatic remiss

✍ Greg W Mattingly, Richard H Weisler, Joel Young, Ben Adeyi, Bryan Dirks… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 238 KB

EPA-0775 – Efficacy of lisdexamfetamine

✍ Dittmann, R.W.; Cardo, E.; Coghill, D.R.; Nagy, P.; Anderson, C.S.; Adeyi, B.; C 📂 Article 📅 2014 🏛 Elsevier Science 🌐 French ⚖ 68 KB

958 – Efficacy of lisdexamfetamine dimes

✍ Lecendreux, M.; Banaschewski, T.; Soutullo, C.; Johnson, M.; Zuddas, A.; Anderso 📂 Article 📅 2013 🏛 Elsevier Science 🌐 French ⚖ 36 KB

EPA-0682 – Investigator-rated symptomato

✍ Adler, L.; Raychaudhuri, A.; Dirks, B. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 French ⚖ 77 KB

Efficacy of lisdexamfetamine dimesylate

✍ David R. Coghill, Tobias Banaschewski… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 333 KB